Non-Small Cell Lung Cancer
Research from Seoul National University, Medical Department in non-small cell lung cancer provides new insights
Published in Medical Imaging Week, December 8th, 2007
"Chest radiographs and computed tomography (CT) findings, along with clinical course, were evaluated Patients complained of subacute dyspnea and hypoxia. Three patients improved after discontinuation of gefitinib, while remaining two showed no response," wrote H.S. Park and colleagues, Seoul National University, Medical Department.
The researchers concluded: "Unilateral or bilateral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week
Source: Medical Imaging Week (2007-12-08)
More Articles from Medical Imaging Week
- Breast Cancer
Aetna Recognized by National Committee for Quality Assurance for Program to Reduce Health Care Disparities - Breast Cancer
Researchers at Munster University publish new data on breast cancer - Breast Cancer Screening
Solis Women's Health Opens Breast Care Center in Arlington, Texas - Breast Cancer Screening
Study results from Eastern Michigan University in the area of breast cancer screening published - Cancer
Scientists at State University of New York, Department of Family Medicine discuss research in cancer - Abscess
Research from S. Serwe et al has provided new information about abscess - More from this issue of Medical Imaging Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
